Vitamin C buyers certified to bring class action suit against Chinese pharma companies
U.S. District Judge Brian M. Cogan certified a class of Vitamin C buyers to bring a price-fixing suit against Chinese pharmaceutical companies. The defendants North China Pharmaceutical Co., Aland (Jiangsu) Nutraceutical Co., Northeast Pharmaceutical Co. and Weisheng Pharmaceutical Co. were found to have more than 60 percent world market share for Vitamin C.
New Jersey food company Ranis Co. was appointed to represent the group seeking damages. Texas maker of animal feed additives Animal Science Products Inc. is the class representative for the group requesting an injunction.
Source: Bloomberg
Related content: Duking It Out in Antitrust Price-Fixing: Class Actions After Dukes (Jay Himes & William Reiss, Labaton Sucharow)
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI